Originally published by FinSMEs on January 23, 2023
Waire Health, a Dunfermline, Scotland, UK-based provider of a remote patient monitoring device, raised £2M in funding.
The round was led by Eos Advisory, and Scottish Enterprise.
The company intends to use the funds to grow its management team, production, and product development capabilities, and expand in global markets including North America.
Led by Dave Hurhangee, CEO and Founder, Waire Health provides a remote patient monitoring device, C-Detect, that operates in hospitals and homes autonomously, reducing costs and improving outcomes through continuous real-time monitoring and advanced artificial intelligence.
The C-Detect device, which has been developed at the company’s Dunfermline headquarters and is manufactured at a facility near Edinburgh, has undergone extensive trials with the University of California, and Waire Health has partnerships in place with organisations ranging from global healthcare organisations to national governments. The company sells platform agnostic sensors primarily to healthcare technology platform providers, who in turn sell into hospitals and other healthcare organisations.
Waire Health is also running a pilot study in partnership with the Irish Government and Indian multinational conglomerate The Tata Group.